News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257,269 Results
Type
Article (13758)
Company Profile (264)
Press Release (243247)
Section
Business (79260)
Career Advice (147)
Deals (13176)
Drug Delivery (29)
Drug Development (50213)
Employer Resources (31)
FDA (5650)
Job Trends (5105)
News (143805)
Policy (10013)
Tag
Academia (903)
Africa (145)
Allergies (30)
Alliances (21431)
Alzheimer's disease (693)
Antibody-drug conjugate (ADC) (33)
Approvals (5620)
Arizona (39)
Artificial intelligence (40)
Asia (16692)
Australia (2796)
Bankruptcy (96)
Best Places to Work (4385)
Biotechnology (221)
Breast cancer (36)
C2C Services and Suppliers (10636)
California (1380)
Canada (539)
Cancer (382)
Career advice (128)
CAR-T (36)
Cell therapy (111)
China (102)
Clinical research (39232)
Collaboration (118)
Colorado (47)
Compensation (57)
Connecticut (48)
COVID-19 (988)
Cystic fibrosis (61)
Data (335)
Diabetes (46)
Diagnostics (1170)
Earnings (28389)
Europe (35827)
Events (45992)
Executive appointments (115)
FDA (5811)
Florida (144)
Funding (123)
Gene editing (32)
Gene therapy (91)
GLP-1 (267)
Government (1057)
Healthcare (6522)
Hotbed/Location (184203)
Illinois (87)
Indiana (45)
Infectious disease (1003)
Inflammatory bowel disease (80)
IPO (7147)
Job creations (857)
Job search strategy (124)
Kansas (52)
Layoffs (178)
Legal (1370)
Lung cancer (78)
Manufacturing (44)
Maryland (216)
Massachusetts (1132)
Medical device (2526)
Medtech (2527)
Mergers & acquisitions (6061)
Metabolic disorders (156)
Michigan (39)
Minnesota (71)
Neuroscience (829)
New Jersey (368)
New York (439)
NextGen Class of 2024 (1985)
Non-profit (840)
North Carolina (347)
Northern California (600)
Obesity (89)
Ohio (66)
Opinion (87)
Parkinson's disease (45)
Patents (37)
Pennsylvania (306)
People (24775)
Pharmaceutical (42)
Phase I (13767)
Phase II (18236)
Phase III (11606)
Pipeline (95)
Postmarket research (845)
Preclinical (5789)
Radiopharmaceuticals (199)
Rare diseases (116)
Real estate (1407)
Regulatory (8071)
Research institute (930)
South America (207)
Southern California (572)
Startups (1963)
Texas (130)
United States (5234)
Vaccines (141)
Washington State (164)
Weight loss (62)
Date
Last 7 days (387)
Last 30 days (1511)
Last 365 days (21138)
2024 (15858)
2023 (22413)
2022 (26827)
2021 (27811)
2020 (23371)
2019 (16239)
2018 (11755)
2017 (13753)
2016 (11850)
2015 (14358)
2014 (10400)
2013 (7497)
2012 (7542)
2011 (7625)
2010 (7434)
257,269 Results for "novus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
September 24, 2024
·
6 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial.
October 4, 2024
·
1 min read
·
Angela Gabriel
Biotech Beach
Novus Therapeutics Announces Results of Special Meeting of Stockholders
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those living with immunological diseases, today announced results from a special meeting of stockholders that was held on Friday, December 19, 2020. During the meeting, Novus’ stockholders approved a proposal for the issuance
December 22, 2020
·
3 min read
Deals
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. (“Anelixis”), a privately held clinical stage biotechnology company developing a next generation anti-CD40 Ligand (CD40L) antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases
September 14, 2020
·
10 min read
Press Releases
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company
September 30, 2024
·
8 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
Business
Novus Therapeutics Appoints June Lee, M.D., to Board of Directors
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those living with immunological diseases, today announced the appointment of June Lee, M.D., to the company’s Board of Directors.
December 9, 2020
·
5 min read
Business
Novus Therapeutics Reports Third Quarter 2020 Financial Results
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those living with immunological diseases, today reported its financial results for the quarter ended September 30, 2020, and operationa
November 16, 2020
·
9 min read
1 of 25,727
Next